Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate Pretreatment in Chronic Lymphocytic Leukemia
NCT02144623Phase 1Completed
- Sponsor
- Skåne University Hospital
- Start
- Jan 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of valproic acid in chronic lymphocytic leukemia (CLL), sponsored by Skåne University Hospital. Primary endpoint: Levels of CD20 protein and messengerRNA. Started Jan 2015; status: completed.
02
Drugs
valproic acid
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02144623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144623.